8-KCorporate ChangesExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Code of Ethics Amendment (Oct 27, 2004)

Filed October 27, 2004For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 27, 2004, reporting amendments to its Code of Business Ethics, effective October 21, 2004. These amendments focus on enhancing the company's internal governance and ethical compliance procedures. Specifically, the changes establish a formal process for disclosing and reviewing potential conflicts of interest for all employees, executive officers, and directors. This filing is important for investors as it signals the company's commitment to strong corporate governance and transparency. By formalizing conflict of interest procedures, Quest Diagnostics is reinforcing its ethical framework, which can contribute to long-term stakeholder trust and reduce potential risks associated with conflicts of interest. The amended code is publicly available, allowing investors to review the company's ethical standards.

Key Highlights

  • 1Quest Diagnostics amended its Code of Business Ethics on October 21, 2004.
  • 2The amendments establish a process for disclosing and reviewing potential conflicts of interest.
  • 3These changes apply to all employees, executive officers, and directors.
  • 4The amendments clarify that a determination of no actual conflict of interest is not a waiver of ethical provisions.
  • 5The updated Code of Business Ethics is available as an exhibit to the 8-K and on the company's website.
  • 6This filing demonstrates a focus on corporate governance and ethical compliance.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform the U.S. Securities and Exchange Commission (SEC) and the public about amendments made to Quest Diagnostics' Code of Business Ethics, which became effective on October 21, 2004.

The key changes involve establishing a formal process for disclosing and reviewing potential conflicts of interest for all employees, executive officers, and directors. Additionally, the amendments clarify that a determination that a disclosed relationship does not constitute an actual conflict of interest will not be considered a waiver of the code's provisions.

Changes to a Code of Ethics, especially those focusing on conflict of interest procedures, are important for investors as they reflect a company's commitment to strong corporate governance, ethical conduct, and risk management. Robust ethical frameworks can enhance transparency, build stakeholder trust, and potentially mitigate legal and reputational risks.

The amended and restated Code of Business Ethics is attached as Exhibit 14 to this 8-K filing and is also available in the Corporate Governance Section of Quest Diagnostics' official website (www.questdiagnostics.com).